Results 101 to 110 of about 54,069 (122)

Efficacy and safety of doravirine/islatravir in heavily treatment-experienced participants living with HIV-1: results from a randomized trial. [PDF]

AIDS
Carr A, Mngqibisa R, Khaertynova I, Kumar PN, Haider S, Zhang Y, Correll T, Asante-Appiah E, Greaves W.   +8 more
europepmc   +1 more source

Prevalence and risk factors of viral hepatitis and HIV among people experiencing homelessness in Germany based on a nationwide study. [PDF]

Sci Rep
Heinrich F, Wong TLE, Graf W, Dost K, Brennecke A, Kowalski V, van Rüth V, Iwersen-Bergmann S, Hajek A, König HH, Renné T, Brehm TT, Pfefferle S, Schulze Zur Wiesch J, Dandri M, Aepfelbacher M, Püschel K, Ondruschka B, Lütgehetmann M, Stallbaum F.   +19 more
europepmc   +1 more source

volume 77, no. 4, April 1977 [PDF]

, 1977

core   +1 more source

Beyond mild, moderate, and severe traumatic brain injury: modelling severity from clinical, neuroimaging, and blood-based indicators. [PDF]

EBioMedicine
Nelson LD, Magnus BE, Yue JK, Balsis S, Patrick CJ, Temkin N, Yuh EL, Diaz-Arrastia R, Ryu E, Maas AIR, Menon DK, Wilson L, Manley GT, TRACK-TBI Investigators, CENTER-TBI Participants and Investigators.   +14 more
europepmc   +1 more source

Synthesizing and assessing influenza vaccine evidence: Strengths and limitations of the recent ECDC report on the effectiveness of new and enhanced influenza vaccines. Communication on: the "European Centre for Disease Prevention and Control. Systematic review update on the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory confirmed influenza in individuals aged 18 years and over. Stockholm: ECDC; 2024". [PDF]

Germs
Kassianos G, Civljak R, van Essen GA, Pecurariu OF, Froes F, Galev A, Kõivumägi K, Kristufkova Z, Kuchar E, Kyncl J, Maltezou HC, Marković M, Mosnier A, Leonardo ROLY, Rossi A, Schelling J.   +15 more
europepmc   +1 more source

Comparing blastocyst euploid rates between the progestin-primed and gonadotrophin-releasing hormone antagonist protocols in aneuploidy genetic testing: a randomised trial protocol. [PDF]

BMJ Open
Li H, Yu M, Zhang W, Chen J, Chen H, Lu X, Li L, Ng EHY, Sun X.   +8 more
europepmc   +1 more source

Normal Infant Immunologic Assessment and Uneventful Live Rotavirus Vaccination Despite Continuous Tofacitinib Exposure In Utero and During Breastfeeding. [PDF]

Crohns Colitis 360
Ernest-Suarez K, Murguía-Favela LE, Novak KL, Panaccione R, Constantinescu C, Seow CH.   +5 more
europepmc   +1 more source

Defining high bleeding risk in patients undergoing transcatheter aortic valve implantation: a VARC-HBR consensus document. [PDF]

EuroIntervention
Garot P, Morice MC, Angiolillo DJ, Cabau JR, Park DW, Van Mieghem NM, Collet JP, Leon MB, Sengottuvelu G, Neylon A, Ten Berg JM, Mylotte D, Tchétché D, Krucoff MW, Reardon MJ, Piazza N, Mack MJ, Généreux P, Makkar R, Hayashida K, Ohno Y, Mochizuki S, Shirai Y, Matsumara R, Jin Y, Webb JG, Cutlip DE, Chen M, Spitzer E, Mehran R, Capodanno D.   +30 more
europepmc   +1 more source

Lesion-Level Effects of LDL-C-Lowering Therapy in Patients With Acute Myocardial Infarction: A Post Hoc Analysis of the PACMAN-AMI Trial.

JAMA Cardiol
Biccirè FG, Kakizaki R, Koskinas KC, Ueki Y, Häner J, Shibutani H, Lønborg J, Spitzer E, Iglesias JF, Otsuka T, Siontis GCM, Stortecky S, Kaiser C, Ambühl M, Morf L, Ondracek AS, van Geuns RJ, Spirk D, Daemen J, Mach F, Windecker S, Engstrøm T, Lang I, Losdat S, Räber L.   +24 more
europepmc   +1 more source

Doravirine/Islatravir (100/0.75 mg) Once-Daily Compared With Bictegravir/Emtricitabine/Tenofovir Alafenamide as Initial HIV-1 Treatment: 48-Week Results From a Phase 3, Randomized, Controlled, Double-Blind, Noninferiority Trial. [PDF]

Clin Infect Dis
Rockstroh JK, Paredes R, Cahn P, Molina JM, Sokhela SM, Hinestrosa F, Kassim S, Cunningham D, Ghosn J, Bogner JR, Gatanaga H, Asante-Appiah E, Zhang Y, Nwoke U, Klopfer SO, Eves K, Squires K, Correll T, Fox MC, Pisculli ML.   +19 more
europepmc   +1 more source